Ferinject Ferric Maltose Injection 500 Mg About
Ferinject Ferric Maltose Injection 500 Mg stands as a best-seller among hematological agents, celebrated for its kingly efficacy in treating iron deficiency anemia, especially where oral iron fails or causes intolerance. This formidable intravenous solution, crafted with impeccable precision, garners favorable reviews globally. With approval in major regulated markets-including Canada, the UK, the USA, Europe, and Australia-Ferinject ensures outstanding patient outcomes. Its dark brown solution is internationally exported, and each 10 mL vial contains a potent 500 mg of ferric carboxymaltose, making it the deal of choice for swift iron replenishment under strict medical supervision.
Application Areas, Directions, and Exclusive Features
Ferinject Ferric Maltose Injection 500 Mg is ideally suited for adults and adolescents above 14 years confronting iron deficiency anemia-particularly cases unresponsive or intolerant to oral iron formulations. Administered intravenously by healthcare professionals, this injection boasts fast-acting results. Its high concentration of 500 mg per 10 mL vial ensures efficient iron replacement. With a shelf life of up to 24 months and easy storage below 25C protected from light, Ferinject is both practical and effective in clinical environments.
Delivery, Domestic Market Reach, and Sample Policy
Ferinject Ferric Maltose Injection 500 Mg is available across the domestic market at a competitive expenditure rate, with delivery timelines tailored to healthcare procurement needs. The main domestic mar includes hospitals and clinics throughout India, with swift logistical support for healthcare providers. Sample policies are customer-centric, ensuring quality verification prior to bulk orders. Each unit is meticulously packed with one vial per box to maintain impeccable quality standards until it reaches the end user.
FAQ's of Ferinject Ferric Maltose Injection 500 Mg:
Q: How should Ferinject Ferric Maltose Injection 500 Mg be administered?
A: Ferinject must be administered intravenously by a healthcare professional. The dosage and frequency depend on individual patient requirements and are determined by the physician.
Q: What are the primary application areas for Ferinject Ferric Maltose Injection?
A: Ferinject is primarily recommended for adults and adolescents aged 14 and above with iron deficiency anemia, particularly in cases where oral iron supplements are ineffective or not tolerated.
Q: When can I expect results from this iron supplementation?
A: Ferinject typically shows improvement in iron levels and anemia symptoms within just a few weeks post-infusion, depending on initial iron stores and individual patient response.
Q: Where is Ferinject Ferric Maltose Injection available for supply?
A: This product is exported globally from India to regulated markets including Canada, the UK, USA, Europe, and Australia, as well as available across the Indian domestic market.
Q: What precautions should be observed during the administration process?
A: Administration should occur under medical supervision, with close monitoring for potential hypersensitivity or injection site reactions. It should not be used in patients with iron overload syndromes or known hypersensitivity to ferric carboxymaltose.
Q: What are the benefits of choosing Ferinject for iron supplementation?
A: Ferinject offers swift, direct restoration of iron levels, making it especially beneficial for patients unable to tolerate oral preparations or requiring rapid correction of anemia.